Mohan @mohanraj9706

x.com/mohanraj9706 Uppsala Joined June 2010

Tweets

47
Followers

85
Following

513
Likes

50

Mohan @mohanraj9706

2 years ago

Read our recent publication in @CCR_AACR on how characteristics of #CARTcell infusion product influences treatment outcome in #lymphoma patients. Congratulations to authors @tina_saren , @EssandLab from @UU_University at @IgpUu

Clinical Cancer Research @CCR_AACR

2 years ago

0 1 3 1K 0

Download Image

0 3 3 699 0

Tina Sarèn @tina_saren

2 years ago

Curious to know the clinical outcome of our study and how characteristics of the CAR-T infusion products may effect? Read our latest publication in @CCR_AACR ! Thank you to everyone involved in this work😍@EssandLab @mohanraj9706 #immunotherapy #CARTcell aacrjournals.org/clincancerres/…

0 3 4 334 0

Mohan @mohanraj9706

2 years ago

Elicera Therapeutics publishes a scientific article in @NatureComms about the CAR T construct in the ELC-401 program | @EliceraTx, #cartcell, #tcell, #glioma, #cancerResearch, #cancer #celltherapy, #Immunotherapy, @IgpUu, @UU_University. nature.com/articles/s4146…

0 1 1 74 0

Bertrand Delsuc @BertrandBio

2 years ago

I don't know if that's the only root cause of tonic signaling but great work by $ELIC researchers. Makes sense wrt $ACLX eg who don't use scFv's but D-Domains. Complementarity-determining region clustering may cause CAR-T cell dysfunction nature.com/articles/s4146…

1 4 12 3K 2

Mohan @mohanraj9706

2 years ago

Read our latest article published in @NatureComms on how single chain fragments in CARs cause tonic signalling and affect CAR-T cell function. Congratulations to @EssandLab and @tina_saren. #Immuntherapie , #cartcells, #cancer, #cellthetapy, #genetherapy, #Tcells

Essand Lab @EssandLab

2 years ago

0 1 6 140 0

0 0 2 66 0

DimbergLab @DimbergLab

2 years ago

Curious on how we modified blood vessels to boost immunity and treat brain cancer? 💉🧠 Our new publication is out now on @Cancer_Cell ! Big congrats to the first authors of this work, @mohanraj9706 , @AleVaccaro93 & @tiarnevdw , and to the whole team 🥳 cell.com/cancer-cell/fu…

4 21 63 8K 7

Cancer Cell @Cancer_Cell

2 years ago

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma dlvr.it/SqZ6Kv

0 20 57 19K 7

Cancer Discovery @CD_AACR

2 years ago

Read this week's #ResearchWatch: AAV-Mediated Gene Delivery of LIGHT Prolongs Survival in #Glioblastoma, summarizing the work of @mohanraj9706, @AleVaccaro93, @tiarnevdw, Magnus Essand, @DimbergLab et al. bit.ly/3q5eQLg @UU_University

0 6 16 3K 1

Download Image

Mohan @mohanraj9706

2 years ago

Our recent work on AAV-mediated #Immunotherapy for #Glioblastoma is highlighted by @CD_AACR.

Cancer Discovery @CD_AACR

2 years ago

Our recent work on AAV-mediated #Immunotherapy for #Glioblastoma is highlighted by @CD_AACR.

0 6 16 3K 1

Download Image

0 2 7 422 0

Cancer Cell @Cancer_Cell

2 years ago

Online Now: Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma dlvr.it/Sp6vzN

0 8 31 7K 4

Marit Melssen @maritmelssen

2 years ago

Check out the latest publication from our group to learn about how targeting blood vessels can improve the immune response in glioma! Wonderful work by @mohanraj9706 @AleVaccaro93 @tiarnevdw et al.

DimbergLab @DimbergLab

2 years ago

Check out the latest publication from our group to learn about how targeting blood vessels can improve the immune response in glioma! Wonderful work by @mohanraj9706 @AleVaccaro93 @tiarnevdw et al.

4 21 63 8K 7

0 2 3 653 0

Luuk van Hooren @LuukvanHooren

2 years ago

@DimbergLab @Cancer_Cell @mohanraj9706 @AleVaccaro93 @tiarnevdw Amazing paper & super promising therapeutic approach! Honored to have made a small contribution to this in the early days of the project. And the figures and videos are stunning, teaching material for immunology students!❤️ Congrats to all the co-authors on this achievement!! 👍

1 1 3 155 0

Mohan @mohanraj9706

3 years ago

Exciting to share our #cartcell work.. #Immunotherapy #Science

Nature Biomedical Engineering @natBME

3 years ago

Exciting to share our #cartcell work.. #Immunotherapy #Science

0 6 15 0 2

Download Image

0 0 1 0 0

STorM SciLifeLab @STorMSciLifeLab

3 years ago

Exciting new work from @MagnusEssand’s group published in Nat Biomed Eng. reporting how arming CAR-T cells with neutrophil-activating protein (NAP) can improve their efficacy in solid tumors Congratulations @chuanjin @JingMa @mohanraj9706 @diyu 👏 nature.com/articles/s4155…

0 4 12 0 0

Jernberg Wiklund Lab @wiklundlab

4 years ago

We are proud to share the publication of our review: One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies mdpi.com/1303392 @Epigenomes @UU_University @IgpUu @helenajwiklund @nylund_patrick @bertagzabala

0 6 6 0 0

Tiarne van de Walle @tiarnevdw

4 years ago

Curious about lymph node-like structures in the central nervous system? 🤔 What about their possible effects on brain cancer? 🧠 See our new review to learn more! frontiersin.org/articles/10.33…

DimbergLab @DimbergLab

4 years ago

0 3 10 0 0

0 2 5 0 0

Frontiers - Immunology @FrontImmunol

4 years ago

New Research: Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma: Glioblastoma is the most common and aggressive brain tumor, which is uniformly lethal due to its extreme invasiveness and the absence of… frontiersin.org/articles/10.33… #immunology

0 4 8 0 2

DimbergLab @DimbergLab

4 years ago

Can tertiary lymphoid structures be good tools to fight brain cancer? 🧠Check out our newly published review for some insight!🧐frontiersin.org/articles/10.33… @tiarnevdw @AleVaccaro93 @mohanraj9706 @IlkkaPietil @AnnaDimberg @FrontImmunol

0 3 10 0 0

Jonathan Kipnis 💔🎗️ @jonykipnis

4 years ago

I hope that major journals will consider changing their EndNote styles to highlight all co-first authors. What should the next steps be to make a real change? || First authors: is co-equal genuinely equal? nature.com/articles/d4158…

10 42 271 0 8

DimbergLab @DimbergLab

4 years ago

Exciting news!🤩 Check out our recently published work on the role of ELTD-1 in vascular phenotype and immune infiltration in glioma🧠🔬! academic.oup.com/neuro-oncology… @kalyani05v @tiarnevdw @mohanraj9706 @LuukvanHooren @AnnaDimberg @VascBioUpp @IgpUu @UU_University